Skip to main content
. 2008 Jul 25;66(4):517–528. doi: 10.1111/j.1365-2125.2008.03248.x

Figure 2.

Figure 2

Differences in mercaptopurine (6-MP) metabolite concentrations (mean ± SE) among the various polymorphisms studied in acute lymphoblastic leukaemia (ALL) (A,B,C) and inflammatory bowel disease (IBD) (D,E,F) patients. Mutant refers to any mutant (homozygote or heterozygote). P-values were adjusted for multiple testing as per the Bonferroni justification